FdaApplication

NDA 219835

Back to search

Identifiers

Properties

PropertyValue
applicant_nameRIGEL PHARMACEUTICALS INC
application_typeNDA
approval_date2026-05-01

Products (2)

ProductActive ingredientStrengthDosage form
VEPPANUVEPDEGESTRANT100MGTABLET;ORAL
VEPPANUVEPDEGESTRANT200MGTABLET;ORAL

2 products